Your browser doesn't support javascript.
loading
Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms.
Aranda-Rivera, Ana Karina; Cruz-Gregorio, Alfredo; Amador-Martínez, Isabel; Medina-Campos, Omar Noel; Garcia-Garcia, Misael; Bernabe-Yepes, Bismarck; León-Contreras, Juan Carlos; Hernández-Pando, Rogelio; Aparicio-Trejo, Omar Emiliano; Sánchez-Lozada, Laura Gabriela; Tapia, Edilia; Pedraza-Chaverri, José.
Afiliación
  • Aranda-Rivera AK; Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, 04510, Mexico. Electronic address: anitaaranda023@comunidad.unam.mx.
  • Cruz-Gregorio A; Departamento de Fisiología, Instituto Nacional de Cardiología "Ignacio Chavez", Mexico City, 14080, Mexico.
  • Amador-Martínez I; Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, 04510, Mexico.
  • Medina-Campos ON; Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico.
  • Garcia-Garcia M; Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiologia "Ignacio Chávez", Mexico City, 14080, Mexico.
  • Bernabe-Yepes B; Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiologia "Ignacio Chávez", Mexico City, 14080, Mexico.
  • León-Contreras JC; Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico.
  • Hernández-Pando R; Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico.
  • Aparicio-Trejo OE; Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiologia "Ignacio Chávez", Mexico City, 14080, Mexico.
  • Sánchez-Lozada LG; Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiologia "Ignacio Chávez", Mexico City, 14080, Mexico.
  • Tapia E; Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiologia "Ignacio Chávez", Mexico City, 14080, Mexico.
  • Pedraza-Chaverri J; Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico. Electronic address: pedraza@unam.mx.
Free Radic Biol Med ; 212: 49-64, 2024 02 20.
Article en En | MEDLINE | ID: mdl-38141891
ABSTRACT
Releasing unilateral ureteral obstruction (RUUO) is the gold standard for decreasing renal damage induced during unilateral ureteral obstruction (UUO); however, the complete recovery after RUUO depends on factors such as the time and severity of obstruction and kidney contralateral compensatory mechanisms. Interestingly, previous studies have shown that kidney damage markers such as oxidative stress, inflammation, and apoptosis are present and even increase after removal obstruction. To date, previous therapeutic strategies have been used to potentiate the recovery of renal function after RUUO; however, the mechanisms involving renal damage reduction are poorly described and sometimes focus on the recovery of renal functionality. Furthermore, using natural antioxidants has not been completely studied in the RUUO model. In this study, we selected sulforaphane (SFN) because it activates the nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that induces an antioxidant response, decreasing oxidative stress and inflammation, preventing apoptosis. Thus, we pre-administrated SFN on the second day after UUO until day five, where we released the obstruction on the three days after UUO. Then, we assessed oxidative stress, inflammation, and apoptosis markers. Interestingly, we found that SFN administration in the RUUO model activated Nrf2, inducing its translocation to the nucleus to activate its target proteins. Thus, the Nrf2 activation upregulated glutathione (GSH) content and the antioxidant enzymes catalase, glutathione peroxidase (GPx), and glutathione reductase (GR), which reduced the oxidative stress markers. Moreover, the improvement of antioxidant response by SFN restored S-glutathionylation in the mitochondrial fraction. Activated Nrf2 also reduced inflammation by lessening the nucleotide-binding domain-like receptor family pyrin domain containing 3 and interleukin 1ß (IL-1ß) production. Reducing oxidative stress and inflammation prevented apoptosis by avoiding caspase 3 cleavage and increasing B-cell lymphoma 2 (Bcl2) levels. Taken together, the obtained results in our study showed that the upregulation of Nrf2 by SFN decreases oxidative stress, preventing inflammation and apoptosis cell death during the release of UUO.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfóxidos / Obstrucción Ureteral / Antioxidantes Límite: Humans Idioma: En Revista: Free Radic Biol Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfóxidos / Obstrucción Ureteral / Antioxidantes Límite: Humans Idioma: En Revista: Free Radic Biol Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos